Jenne Kyle 4
4 · IONIS PHARMACEUTICALS INC · Filed Mar 13, 2024
Insider Transaction Report
Form 4
Jenne Kyle
EVP, Chf GL Pdt Str Ofcr
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2024-02-26+65,203→ 65,203 totalExercise: $46.10From: 2025-02-26Exp: 2034-02-25→ Common Stock (65,203 underlying)
Footnotes (1)
- [F1]Grant on 02/26/2024 to reporting person of stock options under the Ionis Pharmaceuticals, Inc. 2020 Equity Incentive Plan. Following this transaction, the option was exercisable as to 0 shares on 02/26/2024. 25% of the shares subject to the option will vest and become exercisable on 02/26/2025. Thereafter, the remaining shares subject to the option will vest and become exercisable in 36 equal monthly installments over the next 3 years.